Internal Medicine, Medical Oncology · Ankeny, IA
NPI
1184737504
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1950 SW Magazine Rd
Ankeny, IA, 50023
Phone (515) 282-2921
Groups this clinician bills Medicare through
Medicare paid, 2024
$568K
27,852 services
Medicare patients, 2024
772
Average age 74
Drug cost, 2024
$6.4M
3,183 prescriptions
Company payments, 2025
$17.22
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel M Buroker was code 85025 (blood count), 1,756 times for 391 patients. In total Daniel M Buroker billed 27,852 services in 113 codes, and Medicare paid $568K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 1,756 | 391 | $7.58 | $13K |
| 80053 Clinical Chemistry | Office | 1,488 | 367 | $10.31 | $15K |
| 36415 Venipuncture Blood Collection | Office | 1,244 | 368 | $8.61 | $11K |
| 99214 Office E&M - Established | Office | 1,131 | 440 | $88.04 | $100K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 867 | 465 | $11.96 | $10K |
| 99213 Office E&M - Established | Office | 420 | 295 | $57.02 | $24K |
| 99215 Office E&M - Established | Office | 260 | 161 | $128.29 | $33K |
| 83540 Clinical Chemistry | Office | 216 | 91 | $6.34 | $1,369 |
| 83550 Clinical Chemistry | Office | 216 | 91 | $8.57 | $1,851 |
| 82728 Clinical Chemistry | Office | 216 | 91 | $13.36 | $2,886 |
| 84443 Clinical Chemistry | Office | 208 | 47 | $16.46 | $3,424 |
| 84439 Clinical Chemistry | Office | 207 | 47 | $8.80 | $1,821 |
| 82784 Immunoassay | Office | 159 | 12 | $9.11 | $1,449 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 129 | 12 | $137.95 | $18K |
| 83735 Clinical Chemistry | Office | 106 | 25 | $6.45 | $683 |
By year: 2022 $723K for 33,278 services; 2023 $596K for 22,582 services; 2024 $568K for 27,852 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,756 | 391 | $7.58 | $13K |
| 80053 Clinical Chemistry | 1,488 | 367 | $10.31 | $15K |
| 36415 Venipuncture Blood Collection | 1,244 | 368 | $8.61 | $11K |
| 83550 Clinical Chemistry | 216 | 91 | $8.57 | $1,851 |
| 82728 Clinical Chemistry | 216 | 91 | $13.36 | $2,886 |
| 83540 Clinical Chemistry | 216 | 91 | $6.34 | $1,369 |
| 84443 Clinical Chemistry | 208 | 47 | $16.46 | $3,424 |
| 84439 Clinical Chemistry | 207 | 47 | $8.80 | $1,821 |
| 82784 Immunoassay | 159 | 12 | $9.11 | $1,449 |
| 83735 Clinical Chemistry | 106 | 25 | $6.45 | $683 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel M Buroker prescribed most often to Medicare patients was Anastrozole, with 396 prescriptions and refills. In total Daniel M Buroker wrote 3,183 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 396 | 828 | 90 | $4,776 |
| Prednisone Generic | 152 | 160 | 43 | $462 |
| Acyclovir Generic | 126 | 162 | 23 | $1,096 |
| Ondansetron Hcl Generic | 125 | 125 | 58 | $864 |
| Potassium Chloride Generic | 119 | 153 | 29 | $1,751 |
| Gabapentin Generic | 117 | 164 | 29 | $1,986 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 105 | 105 | 32 | $2,486 |
| Abiraterone Acetate Generic | 95 | 95 | Under 11 | $70K |
| Levothyroxine Sodium Generic | 93 | 105 | 16 | $252 |
| Eliquis Apixaban | 86 | 124 | 21 | $69K |
| Pantoprazole Sodium Generic | 85 | 100 | 18 | $402 |
| Lenalidomide Generic | 82 | 82 | Under 11 | $969K |
| Dexamethasone Generic | 81 | 96 | 25 | $1,266 |
| Letrozole Generic | 73 | 147 | 15 | $950 |
| Xtandi Enzalutamide | 57 | 57 | Under 11 | $791K |
Brand drugs: - claims; generic drugs: 2,693 claims; opioid claims: 231.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel M Buroker $17.22 ($17.22 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $17.22.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $17.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.